Rigel Pharmaceuticals Inc
SWB:RI2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rigel Pharmaceuticals Inc
SWB:RI2A
|
US |
|
I
|
Infosys Ltd
SWB:IOY
|
IN |
|
S
|
SS&C Technologies Holdings Inc
F:WGSA
|
US |
|
Q
|
QinetiQ Group PLC
DUS:QY6
|
UK |
|
B
|
Bank of America Corp
BMV:BAC
|
US |
|
Promotora y Operadora de Infraestructura SAB de CV
BMV:PINFRAL
|
MX |
|
Nolato AB
LSE:0OA9
|
SE |
|
Sopra Steria Group SA
PAR:SOP
|
FR |
|
S
|
SSR Mining Inc
LSE:0VGE
|
CA |
|
T
|
Taiheiyo Cement Corp
XBER:TIE
|
JP |
|
M
|
Metro AG
XBER:B4B3
|
DE |
|
Ctp NV
F:3YZ
|
NL |
|
H
|
H2O Innovation Inc
TSX:HEO
|
CA |
|
A
|
ASGN Inc
F:OA2
|
US |
|
Fairvest Ltd
F:2T20
|
ZA |
|
C
|
Coherent Corp
F:H7B
|
US |
|
Transgene SA
OTC:TRGNF
|
FR |
|
L
|
Lamar Advertising Co
DUS:6LA
|
US |
|
I
|
Indosat Tbk PT
F:IDO1
|
ID |
|
C
|
Coeur Mining Inc
XBER:CDM1
|
US |
|
T
|
Trade Desk Inc
F:TT8
|
US |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
D
|
Discovery Ltd
XMUN:D3H
|
ZA |
|
B
|
Barrick Gold Corp
F:ABR
|
CA |
Bankruptcy Probability
Rigel Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rigel Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
536.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
239.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rigel Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rigel Pharmaceuticals Inc has total debt of 15m USD. This includes both short-term (0 USD) and long-term (15m USD) debt.
You can find a full breakdown on its Balance Sheet.
